No profile data available.
Stemtech Corporation (STEK) is a healthcare company in the nutritional and natural health products industry, based in Naples, United States.
It reported revenue of $2.88 million for fiscal year 2025, down 43.1% from fiscal year 2024, and net income of -$4.05 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $629,312, down 9.8% from a year before. Latin America was its largest region in fiscal year 2024, with 53% of revenue. Its market capitalization was $299,703 as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 8, 2026.
Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia.
Stemtech reported $2.88 million in revenue for fiscal year 2025, down 43.1% from $5.05 million in fiscal year 2024. In Q2 2026 revenue was $629,312.
Latin America: 53% of revenue by region in fiscal year 2024, followed by Americas (43%).
$299,703 as of October 8, 2026.
Listed companies of a similar size in the same industry (nutritional and natural health products) include Therapeutic Solutions International, Inc. (TSOI), NuVim, Inc. (NUVM), Cyios Corporation (CYIO), BioAdaptives, Inc. (BDPT).